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To make faster and efﬁcient the identiﬁcation of mRNA targets common to more than one miRNA, and to
identify new miRNAs modulated in speciﬁc pathways, a computer program identiﬁed as SID1.0 (simple
String IDentiﬁer) was developed and successfully applied in the identiﬁcation of deregulated miRNAs in
prostate cancer cells. This computationally inexpensive Fortran program is based on the strategy of
exhaustive search and speciﬁcally designed to screen shared data (target genes, miRNAs and pathways)
available from PicTar and DIANA-MicroT 3.0 databases. As far as we know this is the ﬁrst software
designed to ﬁlter data retrieved from available miRNA databases. SID1.0 takes advantage of the standard
Fortran intrinsic functions for manipulating text strings and requires ASCII input ﬁles. In order to dem-
onstrate SID1.0 applicability, some miRNAs expected from the literature to associate with cancerogenesis
(miR-125b, miR-148a and miR-141), were randomly identiﬁed as main entries for SID1.0 to explore
matching sequences of mRNA targets and also to explore KEGG pathways for the presence of ID codes
of targeted genes. Besides genes and pathways already described in the literature, SID1.0 has proven
to useful for predicting other genes involved in prostate carcinoma. These latter were used to identify
new deregulated miRNAs: miR-141, miR-148a, miR-19a and miR-19b. Prediction data were preliminary
conﬁrmed by expression analysis of the identiﬁed miRNAs in androgen-dependent (LNCaP) and indepen-
dent (PC3) prostate carcinoma cell lines and in normal prostatic epithelial cells (PrEC).
 2011 Elsevier Inc. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are small non-coding RNAs that take part
in post-transcriptional regulation either by arresting the transla-
tion or by cleavage (degradation) of mRNA targets [1]. MicroRNA
regulation is performed through pairing of the miRNA to sites in
the messenger RNA of protein coding genes. MicroRNAs have been
thought to be involved in many biological processes (i.e. cell prolif-
eration, death and differentiation) and are believed to regulate the
expression of approximately one-third of all human genes [2]. Ma-
ture miRNAs bind to their target mRNAs by complete or incom-
plete complementation of their 50-end nucleotides 1–8 (seed
sequences) with a binding site in the 30- or 50-untranslated regions
(UTRs) of target transcripts or in the coding sequences [3]. This
process results in direct cleavage of the targeted mRNAs or inhibi-
tion of translation. Currently, nearly 800 humanmiRNAs have beenll rights reserved.
ertini).identiﬁed. Target-prediction computer programs often predict that
a miRNA could target tens to hundreds of genes, and that a gene
can be targeted by many miRNAs. Thus, the expectation that miR-
NAs play important roles in coordinating many cellular processes,
particularly those involved in development and disease, and even
in various cancers [4,5]. Prediction servers such as TargetScan [6],
miRanda [7], RNAhybrid [8], PicTar [9] and the recent DIANA-
MicroT 3.0 [10] provide information about the miRNA-target
interactions. This latter, in particular, has been designed to cover a
quick and easy interpretation of the involvement of a series of genes
in biological processes. DIANA-MicroT 3.0 actually measures the
enrichment of genes involved in pathways within a given list [10].
It has already been demonstrated that miRNAs are aberrantly
expressed in prostate cancer (CaP) [11]. In androgen-dependent
(AD) and androgen-independent (AI) CaP cell lines differential
expression of miR-148a was found [11]. MiR-125b expression
was reported to be increased in benign prostate lines compared
with CaP lines and androgen receptor positive (AR-positive) cell
lines expressed more miR-125b than androgen receptor negative
(AR-negative) cell lines [5]. It has been recently reported that even
Fig. 1. Workﬂow illustrating the main steps of the informatics and the experimen-
tal procedure. Data from any other available databases can be used in addition to
those indicated here.
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(PrEC and LNCaP) in comparison to AR-negative cell lines (PC3
and DU145) [11]. Furthermore, in humans, a member of the miR-
NA-200 family (miR-141) has been reported to distinguish patients
with prostate cancer from healthy controls [12]. Down-regulation
of miRNA-200 family members has been identiﬁed to be involved
in tumor metastasis [13]. These studies showed that miR-125b,
miR-148a and miR-141 may have a key role in prostate
tumorigenesis.
We developed a simple String IDentiﬁer (SID1.0) to identify
common mRNA targets of miR-125b, miR-148a and miR-141 and
the associated pathways. In order to identify common strings,
SID1.0 performs an exhaustive search within each individual input
ﬁle and reports the result (i.e. the number of common targets) on
an ASCII output ﬁle. More sophisticated search strategies have
not been explored to date, since the size of the input ﬁles (hence
the number of IDs to be scrutinized) is, in the experiments per-
formed so far, limited to a few hundreds or thousands. This makes
the whole procedure computationally inexpensive. SID1.0 has been
developed in a Mac OSX environment and compiled with the Intel
Fortran compiler. As far as we know this is the ﬁrst software de-
signed to ﬁlter data retrieved from available databases (e.g.: Tar-
getScan, miRanda, RNAhybrid, PicTar, DIANA-MicroT 3.0),
allowing us for retrieving new information that is not directly
available from them. The analysis performed by SID1.0, i.e. the
identiﬁcation of common strings, is not directly available through
the user interface of the databases above. It is difﬁcult to evaluate
the strengths or the limitations of alternative computational ap-
proaches because similar tools, possibly developed by other inves-
tigators, have not been described or made available to date.
Moreover, despite its simplicity, this technique can allow to predict
new miRNAs targeting genes modulated in these pathways. To val-
idate the reliability of predictions made by SID1.0, we ascertained
that SID1.0 predicted miRNAs were modulated in CaP (LNCaP
androgen-dependent and PC3 androgen-independent) cells that
were compared with normal prostatic epithelial (PrEC) cells.2. Materials and methods
2.1. Data acquisition
We obtained from PicTar database (see http://pictar.mdc-
berlin.de/) the predicted target genes of the miRNAs we were inter-
ested in. The targets of a miRNA are indicated with a speciﬁc gene
ID system (Refseq ID). For each miRNA a dataset (i.e., a group list of
Refseq IDs) of the predicted targeted genes was created [9]. Since a
visual inspection of the IDs would be unpractical due to their large
number (even thousands IDs), they have been automatically in-
dexed using a simple program written in Fortran (SID1.0; String
IDentiﬁer, see http://www.ﬁs.uniurb.it/spada/SID_minipage.html)
that looks for Refseq IDs shared by the predicted target genes of
the different datasets [14]. In Fig. 1 we show the experimental
workﬂow. SID1.0 is in fact based on an algorithm of sequential
exhaustive search that has been implemented in Fortran 90 using
very elementary methods. SID1.0 performs an exhaustive search
within each individual one-column ASCII input ﬁle and reports
the result (i.e. the number of common targets) on an ASCII output
ﬁle in the form of a table that summarizes the common IDs. Thus,
the main advantage of SID1.0, which works as a ﬁlter on the infor-
mation provided by the web pages hosting the miRNA databases, is
that it is completely independent from the algorithms on which
the databases rely upon. In this way, our procedure builds upon
the prediction algorithms used in the databases, whose outputs
are scrutinized by SID1.0. SID1.0 has been developed and tested
in an Mac OS X environment and is currently compiled using theIntel Fortran 90 compiler. A version of SID1.0 based on the free,
open source g95 compiler is under development.
Each gene in the group list has the related information in NCBI’s
Entrez Nucleotide database. It is possible to perform a reverse
search by obtaining from PicTar database the miRNAs predicted
to target a gene. For each gene a dataset of the miRNAs predicted
to target a gene was created. The names of the miRNAs were in-
dexed using SID1.0, which looks for miRNA names shared by the
predicted targeting miRNAs of the different datasets. Furthermore,
for a deﬁned miRNA name, target genes can be automatically re-
trieved from the DIANA-microT 3.0 database. A list of gene names
or a list of RefSeq IDs are provided and the program translates
them into Ensembl IDs. The list of genes is compared to the Kyoto
Encyclopedia of Genes and Genomes (KEGG) Pathways Database
[10] and IDs are indexed using SID1.0 that looks for KEGGs path-
way IDs shared by the predicted target genes of the different data-
sets. In this way, we were able to obtain the common target genes
of speciﬁc miRNAs, the common targeting miRNAs of speciﬁc genes
and the common pathways of speciﬁc miRNAs (see Fig. 1). PicTar
database is trained to identify both binding sites targeted by a sin-
gle miRNA and those that are co-regulate by several miRNAs in a
coordinated manner.2.2. Cell lines and culture
Prostate epithelial cells (PrEC) were kindly provided by Dr.
Antonella Farsetti from the Department of Experimental Oncology,
Molecular Oncogenesis Laboratory, Experimental Research Center,
Regina Elena (Regina Elena Cancer Institute of Rome, Italy) [15].
The cells were cultured according to the manufacturer’s protocols
(Cambrex BioScience, Verviers, Belgium). Human prostate cancer
cell lines (LNCaP and PC3) were cultured in RPMI 1640 supple-
mented with 10% fetal bovine serum (Invitrogen), 4.5 g/L glucose,
and 0.1 mol/L HEPES, penicillin (100 units/ml) and streptomycin
(100 lg/ml).
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Extraction of miRNAs from cell culture was performed from
1x106 cells per samples by Total RNA Puriﬁcation Kit according
to manufacturer’s protocol (NORGEN). Predicted miRNA expres-
sion was carried out by using TaqMan MicroRNA Assays (Applied
Biosystem). Expression data were normalized according to the Ct
of a miRNA that preliminary experiments showed not to be modu-
lated by CaP pathogenesis, such as U6 snRNA [16]. Relative
amounts of miRNA were calculated by the comparative threshold
cycle (Ct) method as: 2DCt, where DCt = CtmiRNA  CtU6.
2.4. Statistical analysis
Statistical analyses were performed using Student’s t-test for
unpaired data and P-values < 0.05 were considered signiﬁcant.
Data are presented as mean ± SEM.
3. Results
3.1. MicroRNAs and prostate cancer (CaP)
It has already been demonstrated that miRNAs are aberrantly
expressed in prostate cancer (CaP) [11]. Considering that a given
miRNA may have up to 100 mRNA targets, the issue is how to de-
cide which CaP-related targets of the miRNAs may be biologically
active and important. To date computational algorithms have
played a central role in the discovery of the majority of miRNAs
known, as well as in prediction of their targets (and associated
pathways).
Available data in literature suggest that miR-125b, miR-148a
and miR-141 may be related to prostatic tumorigenesis, AI growth
(AR may even regulate their expression) and tumor metastasis
[4,13]. We used these three miRNAs to extract their potential tar-
gets in the searchable database of published miRNA sequences pro-
vided by the miRNA registry. Using SID1.0, we found the common
nucleic acid codes (RefSeq ID datasets) shared by miR-125b, miR-
148a and miR-141 targets. This approach identiﬁed the following
seven common target genes: ATXN1 (ataxin variant 1); RNF44
(ring ﬁnger protein 44); AKAP1 (A kinase anchor protein 1); TRPS1
(trichorhinophalangeal syndrome 1); E2F3 (E2F transcription fac-
tor 3); CPEB4 (cytoplasmic polyadenylation element binding pro-
tein 4) and ESRRG (estrogen-related receptor gamma transcript
variant 1, 2 and 3) (Table 1).
Between them, E2F3 has been already demonstrated to play a
crucial role in the control of cell cycle, in the action of tumor sup-
pressor proteins and it has been even shown to increase with the
down-regulation of miR-125b in human prostate cancer tissues
[17]. It has also been demonstrated that ESRRG may perform an
antiproliferative or tumor-suppressing function in prostate cancer
cell lines [18]. It has been observed that TRPS1 is possibly involvedTable 1
Common targets (RefSeq ID) of hsa-miR-125b (531 elements), hsa-miR-141 (422 element
possible combinations (targets common either to 2 or all of the 3 miRNAs). We reported
corresponding annotation (second column). The database used for this analysis was PicTa
Common RefSeq ID Annotation
NM_000332 Homo sapiens ataxin 1 (ATXN1)
NM_014901 Homo sapiens ring ﬁnger protein 44 (RNF44
NM_139275 Homo sapiens A kinase (PRKA) anchor prote
NM_014112 Homo sapiens trichorhinophalangeal syndro
NM_001949 Homo sapiens E2F transcription factor 3 (E2
NM_030627 Homo sapiens cytoplasmic polyadenylation
NM_001438 Homo sapiens estrogen-related receptor gam
NM_206594 Homo sapiens estrogen-related receptor gam
NM_206595 Homo sapiens estrogen-related receptor gamin oxidative stress and apoptosis in androgen-independent DU145
prostate cancer cells [19], while the remaining predicted target
genes have still not been considered in prostate cancer. By these
results, we can deduce that SID1.0 distinguished some target genes
(E2F3, ESRRG and TRPS1) previously demonstrated to be involved
in prostate tumorigenesis, and that the remaining ones are poten-
tially involved.
3.2. Common pathways potentially altered by the expression of miR-
125b, miR-148a and miR-141
We used the web-based computational database DIANA-MicroT
3.0 to extract the KEGG pathway IDs potentially altered by the
expression of the following miRNAs: miR-125b, miR-148a and
miR-141 (obtaining 3 ID datasets). By using SID1.0 we found the
common KEGG pathway IDs (obtained from the 3 KEGG datasets
of each miRNA) shared by miR-125b, miR-148a and miR-141.
The output of DIANA-MicroT 3.0 is a table that illustrates the num-
ber and name of the genes involved in a determined pathway (i.e.
O-Glycan biosynthesis) and compares it with the expected number
of genes, depending on how many genes compose the speciﬁc
pathway. As shown in Table 2, the name of the common pathways
indentiﬁed by the correspondent KEGG Pathway IDs were only 5:
O-Glycan biosynthesis; mTOR (mammalian Target of Rapamycin)
signaling pathway; glycan structures-biosynthesis 1; Axon guid-
ance and Neuroactive ligand-receptor interaction.
The O-Glycan biosynthesis and glycan structures-biosynthesis 1
pathways are responsible of O-glycosylated glycoproteins biosyn-
thesis which have antigenic properties. mTOR is a key protein ki-
nase controlling signal transduction from various growth factors
and upstream proteins to the level of mRNA translation and ribo-
some biogenesis, with pivotal regulatory effects on cell cycle pro-
gression, cellular proliferation and growth, autophagy and
angiogenesis. Axon guidance pathway represents a key stage in
the formation of neuronal network. Neuroactive ligand-receptor
interaction is important for neuron function. To evaluate the
involvement of these pathways in prostate carcinogenesis we
found support from the literature, where two of these pathways
(O-Glycan biosynthesis and mTOR) have already been described
to be modulated (see Section 4).
3.3. Prediction of modulated miRNAs in CaP cell lines
We used the seven common target genes identiﬁed in the ﬁrst
analysis (Table 1) to evaluate common miRNAs across them. The
number of possible combinations obtained by SID1.0 across the 7
dataset of targets were 41 in total, representing the common genes
across the 7, 4, 3 and 2 datasets (the missing combinations indicate
that any common miRNAs between 6 and 5 datasets were found).
As shown in Table 3, only miR-141 was common across all the 7
target datasets.s) and hsa-miR-148a (434 elements). We found nine common genes on a total of 95
only the common target RefSeq IDs (in the ﬁrst column) to all the miRNAs and their
r.
)
in 1 (AKAP1), nuclear gene encoding mitochondrial protein, transcript variant 2
me I (TRPS1)
F3)
element binding protein 4 (CPEB4)
ma (ESRRG), transcript variant 1
ma (ESRRG), transcript variant 2
ma (ESRRG), transcript variant 3
Table 2
Common pathways (KEGG Pathway IDs) of hsa-miR-125b (92 elements), hsa-miR-141 (111 elements) and hsa-miR-148a (5 elements). We found ﬁve common pathways (to the 3
miRNAs) on a total of 74 total possible combinations (common pathways to either to 2 or all of the 3 miRNAs). In the table are reported only the pathways common to the 3
miRNAs. We indicated the KEGG Pathway name (ﬁrst column), the gene names involved in each pathway (second column) and the identiﬁcation ID of the pathway used by the
KEGG database (third column). The database used for this analysis was DIANA-MicroT 3.0.
KEGG pathway name Gene name KEGG pathway ID
O-Glycan biosynthesis OGT hsa00512
mTOR signaling pathway TSC1, RHEB hsa04150
Glycan structures – biosynthesis 1 ST3GAL3, OGT hsa01030
Axon guidance SEMA6A, CXCL12, EPHA7, NRP1, EPHA2, CDC42 hsa04360
Neuroactive ligand-receptor interaction GRIN2D, GRIN3A, ADRB1, THRB, CALCR, DRD2 hsa04080
Table 3
Common miRNAs predicted to target the genes: ATXN1 (ﬁve elements), RNF44 (27
elements), AKAP1 (25 elements), TRPS1 (50 elements), E2F3 (49 elements), CPEB4
(eight elements) and ESRRG (six elements which were the same in the 3 variants). We
reported only the miRNAs common (column 1) to 7, 4 and 3 different datasets (the
others are not shown) with the corresponding RefSeq ID (second column) and the
annotation (third column). We found 1 common miRNAs (hsa-miR-141) on a total of
41 possible combinations (common miRNAs to 7, 4, 3 and 2 targets). The database
used for this analysis was PicTar.
Common miRNAs RefSeq ID Annotation
hsa-miR-141 NM_000332 ATXN1
NM_014901 RNF44
NM_139275 AKAP1
NM_014112 TRPS1
NM_030627 CPEB4
NM_001438 ESRRG
NM_001949 E2F3
hsa-miR-200a NM_000332 ATXN1
NM_014901 RNF44
NM_001438 ESRRG
NM_001949 E2F3
hsa-miR-301, hsa-miR-152, hsa-miR-148a, NM_001949 E2F3
hsa-miR-148b, hsa-miR-125a, hsa-miR-125b NM_014901 RNF44
NM_139275 AKAP1
NM_014112 TRPS1
hsa-miR-130a, hsa-miR-130b NM_014901 RNF44
NM_139275 AKAP1
NM_014112 TRPS1
NM_001949 E2F3
hsa-miR-96 NM_000332 ATXN1
NM_139275 AKAP1
NM_001438 ESRRG
hsa-miR-23a NM_000332 ATXN1
NM_030627 CPEB4
NM_001438 ESRRG
hsa-miR-19a, hsa-miR-19b NM_014901 RNF44
NM_139275 AKAP1
NM_014112 TRPS1
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modulated in CaP. Then, we decided to evaluate the expression
of some of these miRNAs (hsa-miR-19a; hsa-miR-19b; hsa-miR-
148a; hsa-miR-141) in CaP cell lines: LNCaP androgen-dependent,
PC3 androgen-independent and normal prostatic epithelial (PrEC)
cells. We remark that it is not possible to rank the miRNAs
obtained in the analysis of Table 3, since the biological relevance
cannot be estimated by our informatic procedure. Each prediction
requires an experimental validation. As shown in Fig. 2, all the
miRNAs quantiﬁed were modulated (up-regulated and/or
down-regulated) in the CaP cell lines tested. Some of them,
hsa-miR-141 and hsa-miR-148a, are down-regulated (Fig. 2A and
B): hsa-miR-141 is down-expressed in LNCaP and PC3, while
hsa-miR-148a is down-expressed only in LNCaP compared to PrEC
cells. Conversely, hsa-miR-19a and hsa-miR-19b are up-regulated
(Fig. 2C and D): both of them are highly expressed in PC3 but
down-expressed in LNCaP compared to PrEC cells.We can assume that all the miRNAs analyzed are differentially
expressed in LNCaP androgen-dependent and PC3 androgen-inde-
pendent compared to normal prostatic epithelial (PrEC) cells. Sur-
prisingly, when we extracted the miRNAs targeting the genes
involved in each pathway, (see Table 4), we found most of the miR-
NAs predicted in the previous analysis (Table 3).4. Discussion
Animals encode miRNAs in their genomes which attack protein
coding genes altering protein expression by cleavage or transla-
tional repression. In human malignancies, including prostate can-
cer, miRNAs have shown a capability of distinguishing the
different tissue developmental and differentiation states. In this
study, using miRNAs and related target predictions documented
in PicTar and DIANA-MicroT 3.0 databases, we identiﬁed the miR-
NAs and target genes that potentially cause differences in prostate
cancer. Taking advantage of the above prediction servers we ob-
tained the information for the miRNA-target interactions desired.
By our bioinformatic strategy based on SID1.0, a computationally
inexpensive Fortran 90 program, we identiﬁed shared data (target
genes, miRNA and pathways). SID1.0 performs an exhaustive
search based on the manipulation of characters strings in Fortran.
Given its versatility, SID1.0 can manage different IDs associated
with gene expression, miRNA and pathways (even in large number
and from any available databases). SID1.0 software has been de-
signed to ﬁlter data retrieved from available databases, thus allow-
ing us for retrieving new information that is not directly available
from those databases. Our proposed approach has successfully
identiﬁed some deregulated miRNA in LNCaP androgen-dependent
and PC3 androgen-independent compared to normal prostatic epi-
thelial (PrEC) cells.
By identifying from literature modulated miRNAs in cancero-
genesis and in particular in prostate cancer, we extracted the genes
modulated by miR-125b, miR-148a and miR-141 in PicTar data-
base. The predicted genes were the following: ATXN1 (ataxin var-
iant 1); RNF44 (ring ﬁnger protein 44); AKAP1 (A kinase anchor
protein 1); TRPS1 (trichorhinophalangeal syndrome 1); E2F3 (E2F
transcription factor 3); CPEB4 (cytoplasmic polyadenylation ele-
ment binding protein 4) and ESRRG (estrogen-related receptor
gamma transcript variant 1, 2 and 3) (Table 1).
From the literature it has already been shown that E2F3, ESRRG
and TRPS1 are modulated in prostate cancer: E2F3 controls cell cy-
cle, acts on tumor suppressor proteins and increases with the
down-regulation of miR-125b in human prostate cancer tissues
[17]; ESRRG functions as antiproliferative or tumor-suppressor in
prostate cancer cell lines [18]; TRPS1 is involved in oxidative stress,
and possibly in apoptosis in androgen-independent DU145 pros-
tate cancer cells [19]. The remaining target genes have not been
described in prostate cancerogenesis but seem to be involved in
other pathogenesis mechanisms, ATXN1 expression can be modu-
lated by miR-19a affecting neuropathology [20].
Fig. 2. Relative quantiﬁcation of down-regulated (A and B) and up-regulated (C–D) miRNAs in CaP cell lines (LNCaP androgen-dependent, PC3 androgen-independent and
PrEC normal prostatic epithelial cells). Relative quantiﬁcation was normalized by U6 snRNA endogenous control. Data are presented as mean ± SEM and P-values < 0.05 were
considered signiﬁcant: PrEC vs. U6 snRNA; ⁄PrEC vs. PC3; §PrEC vs. LNCaP.
Table 4
MiRNAs targeting the genes belonging to the previously identiﬁed common
pathways. The genes without our predicted miRNAs are omitted. We indicated the
KEGG Pathway name (ﬁrst column), the gene names involved in each pathway
(second column) and the miRNAs predicted in the previous analysis (third column).
The database used for this analysis was PicTar.
KEGG pathway name Gene name Predicted miRNAs
O-Glycan biosynthesis OGT hsa-miR-141, hsa-
miR-301,
hsa-miR-200a, hsa-
miR-130a,
hsa-miR-130b, hsa-
miR-125a,
hsa-miR-125b.
mTOR signaling pathway TSC1 hsa-miR-141, hsa-
miR-200a.
Glycan structures –
biosynthesis 1
OGT hsa-miR-141.
Axon guidance SEMA6A, CXCL12,
EPHA2
hsa-miR-141, hsa-
miR-200a.
EPHA7 hsa-miR-141, hsa-
miR-200a,
NRP1 hsa-miR-23a
CDC42 hsa-miR-141, hsa-
miR-200a,
hsa-miR-148a, hsa-
miR-148b,
hsa-miR-130a, hsa-
miR-130b.
hsa-miR-200a.
Neuroactive ligand-receptor
interaction
GRIN3A hsa-miR-141, hsa-
miR-200a.
CALCR hsa-miR-141, hsa-
miR-200a
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the pathways altered by miR-125b, miR-148a and miR-141.
SID1.0 was able to predict the common pathways shared by miR-
125b, miR-148a and miR-141: O-Glycan biosynthesis (and glycan
structures-biosynthesis 1); mTOR signaling pathway; Axon guid-
ance and Neuroactive ligand-receptor interaction (Table 2). These
pathways are known to be involved in antigen expression, in cell
proliferation, growth, autophagy, angiogenesis and in the forma-
tion of neuronal network [21,22]. The O-Glycan biosynthesis and
mTOR pathways have already been described to be involved in
prostate cancer. Actually, the functions of carbohydrates present
in normal cells decrease in prostate cancer cells [23]. Furthermore,
it has been demonstrated that the mTOR pathway is dominant over
AR signaling in prostate cancer cells [24] and its inhibition can lead
to suppressed proliferation of aggressive prostate cancer cell lines
in vitro [25]. SID1.0 was able to correctly predict the involvement
of these two pathways and suggests the possible role of the other
pathways in prostate cancerogenesis.
Next, the genes predicted in our previous analysis (Table 1)
were used in the PicTar database to extract the targeting miRNAs.
In this way we were able to predict the modulation of different
miRNAs (Table 3). Between them, we randomly decided to test
hsa-miR-19a; hsa-miR-19b; hsa-miR-148a and hsa-miR-141 in
LNCaP androgen-dependent and PC3 androgen-independent to be
compared to normal prostatic epithelial (PrEC) cells. As shown in
the results section, all these miRNAs were modulated in our CaP
cells (Fig. 1) indicating not only a correct prediction but also differ-
entially expressed miRNAs in androgen-dependent and -indepen-
dent compared to normal prostatic cells. Furthermore, as shown
in Table 4, extracting the miRNAs targeting the genes involved in
each pathway we found most of the miRNAs predicted in the pre-
vious analysis (Table 3). We did not identify any other genes, but
another analysis could be performed with the genes targeting the
miRNAs above. This will be the subject of future investigations.
It is worth to note that our data collectively may predict the
involvement of miRNAs in prostate cancerogenesis. Serum levels
of hsa-miR-141 have been reported to discriminate patients withprostate cancer from healthy controls [12]. In renal cell carcinoma
and colorectal cancer cells, it has been observed a down-regulation
of hsa-miR-141 [26,27] as we observed in our CaP cell lines. As
demonstrated by other authors [11], we observed a down-regula-
620 M.C. Albertini et al. / Journal of Biomedical Informatics 44 (2011) 615–620tion of hsa-miR-148a in PC3 cells compared to PrEC, but we did not
ﬁnd higher levels in LNCaP (on the contrary, its expression was
even more decreased compared to PC3 and PrEC). However, the
functional roles and target genes of miR-148a in prostate
cancer have not yet been documented. The over-expression of
hsa-miR-19a in PC3 androgen-independent cells may decrease
cytotoxic ATXN1 expression while its down-expression in LNCaP
androgen-dependent cells may increase the cytotoxic effect of
ATXN1 as observed in neurodegenerative pathology [20]. Further-
more, hsa-miR-19a showed increased expression upon glioma
progression [28] which could be similarly investigated in the
progression from androgen-dependent to -independent CaP cells.
In line with our results on PC3 androgen-independent cells, over-
expression of hsa-miR-19b has been demonstrated to be involved
in carcinogenesis [29]. Interestingly, our results demonstrated that
this form is down-expressed in LNCaP androgen-dependent cells
compared to PrEC (and PC3 androgen-independent) cells.
5. Conclusions
In view of the relatively large number of data involved in the
analyses described in this study, we conclude that even a simple
program of string identiﬁcation as SID1.0 has proven to be a very
useful system to predict miRNAs involved in tumor progression
thereby representing a potential tool in diagnostics and clinical
monitoring of cancer. From a general stand point SID1.0 is simply
an implementation of a classical and well known search strategy
in computer science. Its merit relies upon the biological application
that is described in this paper.
Comparison of human cancers with the corresponding normal
tissues revealed that some miRNAs are consistently deregulated
in cancer, which may also suggest a direct role of miRNAs in tumo-
urigenesis. Beside to deregulated miRNAs, because of its broad
applicability, the proposed prediction tool can help to identify gene
targets and biological pathways relevant to cancer development
and treatment.
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